publication venue for
- Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial. 2023
- No evidence of improvement in neuropathy after renal transplantation in patients with end stage kidney disease. 2021
- Protection from neuropathy in extreme duration type 1 diabetes.. 26. 2020
- Reduced association between dendritic cells and corneal sub-basal nerve fibers in patients with fibromyalgia syndrome.. 25. 2020
- Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.. 24. 2019
- Biomarkers of CIDP in patients with diabetes or CMT1.. 16 Suppl 1. 2011
- Modulation of intracellular calcium influences capsaicin-induced currents of TRPV-1 and voltage-activated channel currents in nociceptive neurones.. 12. 2007
- Neuropathy and cognitive impairment following vaccination with the OspA protein of Borrelia burgdorferi.. 9. 2004
- Sensory CIDP presenting as cryptogenic sensory polyneuropathy.. 9. 2004
- Quantitative sensory testing: high sensitivity in small fiber neuropathy with normal NCS/EMG.. 7. 2002
- Nerve pathology in the type 1 diabetic dog: effects of treatment with sulindac.. 6. 2001
- Translating diabetic peripheral neuropathy.. 25. 2020
- Comment on European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy.. 11. 2006
- Biomarkers in the diagnosis and therapy of CIDP: Proceedings of the Biomarkers Faculty Meeting; June 8-9, 2010, Athens, Greece. 2011
- Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). 2014
- The coordinate regulation of sensory afferent CNS targeting and CNS longitudinal tract organization in Drosophila during neural development. 2012